» Articles » PMID: 14706253

Preparation and Physicochemical Properties of Niclosamide Anhydrate and Two Monohydrates

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2004 Jan 7
PMID 14706253
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The intent of the study was to prepare and characterize three crystal forms of niclosamide namely the anhydrate and the two monohydrates and to investigate the moisture adsorption and desorption behavior of these crystal forms. The crystal forms were prepared by recrystallization and were characterized by differential scanning calorimetry, thermogravimetric analysis, isoperibol solution calorimetry, Karl Fischer titration, and X-ray powder diffractometry. Moisture adsorption by the anhydrate at increased relative humidities and two temperatures, 30 and 40 degrees C, was measured while the desorption from the monohydrates was determined at 45, 55, and 65 degrees C for monohydrate H(A) and 75, 90, and 100 degrees C for monohydrate H(B). Thermal analysis and solution calorimetry showed that monohydrate H(B) is more stable than monohydrate H(A) and solubility measurements showed the solubility of the crystal forms decreased in the order: anhydrate>>monohydrate H(A)>monohydrate H(B). With an increase in temperature and relative humidity niclosamide anhydrate adsorbed moisture to form monohydrate H(A) by a random nucleation process. Dehydration of monohydrate H(A) at increased temperatures followed zero order kinetics and resulted in a change to the anhydrate. Monohydrate H(B) was transformed to the anhydrate at higher temperatures by a three-dimensional diffusion mechanism.

Citing Articles

Revisiting Niclosamide Formulation Approaches - a Pathway Toward Drug Repositioning.

Jug M, Laffleur F, Millotti G Drug Des Devel Ther. 2024; 18:4153-4182.

PMID: 39308694 PMC: 11416123. DOI: 10.2147/DDDT.S473178.


Dehydration of Niclosamide Monohydrate Polymorphs: Different Mechanistic Pathways to the Same Product.

Mann J, Gao R, Swift J Cryst Growth Des. 2024; 23(7):5102-5111.

PMID: 38510268 PMC: 10950297. DOI: 10.1021/acs.cgd.3c00322.


Desolvation Processes in Channel Solvates of Niclosamide.

Mann J, Gao R, London S, Swift J Mol Pharm. 2023; 20(11):5554-5562.

PMID: 37850910 PMC: 10630950. DOI: 10.1021/acs.molpharmaceut.3c00481.


Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections.

Needham D AAPS Open. 2023; 9(1):9.

PMID: 37073302 PMC: 10101733. DOI: 10.1186/s41120-023-00072-x.


Spray freeze dried niclosamide nanocrystals embedded dry powder for high dose pulmonary delivery.

Zhang S, Yan S, Lu K, Qiu S, Chen X, Wu W Powder Technol. 2022; 415:118168.

PMID: 36533138 PMC: 9746026. DOI: 10.1016/j.powtec.2022.118168.